Search research articles
Contact Us
Filters
Showing results (81-90 of 109) with videos related to
Page
of 11
Sort By:
Journal of Community Health
|
January 2, 2021
The Impact of Socioeconomic Status on the Clinical Outcomes of COVID-19; a Retrospective Cohort Study
Christine Little, Mathilda Alsen, Joshua Barlow, et al.
Antimicrobial Stewardship & Healthcare Epidemiology : ASHE
|
November 17, 2025
Early de-escalation of empiric antibiotic therapy in neutropenic fever: a single-center, retrospective study
Zachary Mostel, Michelle Evans, Douglas Tremblay, et al.
Carcinogenesis
|
February 5, 2019
Comparing the epidemiology, clinical characteristics and prognostic factors of acute myeloid leukemia with and without acute promyelocytic leukemia
Geetanjali R Kamath, Douglas Tremblay, Alexander Coltoff, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
June 5, 2024
Oral Decitabine/Cedazuridine Is an Effective Ambulatory Therapy for Patients With Myelofibrosis Refractory to JAK2 Inhibitor Therapy
Shivani Handa, Ganesh Sivakumar, Andrew Srisuwananukorn, et al.
Acta Haematologica
|
June 12, 2025
Ring Chromosomes in Patients with Myeloid Neoplasms are Associated with a Poor Response to Therapy
Daniel I Nathan, Ronald Hoffman, Daiva Ahire, et al.
Clinical Advances in Hematology & Oncology : H&O
|
December 5, 2017
The effect of novel therapies in high-molecular-risk multiple myeloma
Guido Lancman, Douglas Tremblay, Kevin Barley, et al.
Leukemia
|
December 23, 2024
HMGA2 overexpression with specific chromosomal abnormalities predominate in CALR and ASXL1 mutated myelofibrosis
Shivani Handa, Christoph Schaniel, Joseph Tripodi, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
September 15, 2022
Impact of Fluoroquinolone Prophylaxis on Neutropenic Fever, Infections, and Antimicrobial Resistance in Newly Diagnosed AML Patients
Jessica Caro, Rafael Madero-Marroquin, Nicole Zubizarreta, et al.
Leukemia & Lymphoma
|
November 13, 2019
Risk factors for infections and secondary malignancies in patients with a myeloproliferative neoplasm treated with ruxolitinib: a dual-center, propensity score-matched analysis
Douglas Tremblay, Amber King, Lihua Li, et al.
Scientific Reports
|
November 14, 2019
Metabolic Effects of JAK1/2 Inhibition in Patients with Myeloproliferative Neoplasms
Manali Sapre, Douglas Tremblay, Eric Wilck, et al.
Page
of 11
Search research articles
Search
Showing results (81-90 of 109) with videos related to
Sort By:
Page
of 11
Journal of Community Health
|
January 2, 2021
The Impact of Socioeconomic Status on the Clinical Outcomes of COVID-19; a Retrospective Cohort Study
Christine Little, Mathilda Alsen, Joshua Barlow, et al.
Antimicrobial Stewardship & Healthcare Epidemiology : ASHE
|
November 17, 2025
Early de-escalation of empiric antibiotic therapy in neutropenic fever: a single-center, retrospective study
Zachary Mostel, Michelle Evans, Douglas Tremblay, et al.
Carcinogenesis
|
February 5, 2019
Comparing the epidemiology, clinical characteristics and prognostic factors of acute myeloid leukemia with and without acute promyelocytic leukemia
Geetanjali R Kamath, Douglas Tremblay, Alexander Coltoff, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
June 5, 2024
Oral Decitabine/Cedazuridine Is an Effective Ambulatory Therapy for Patients With Myelofibrosis Refractory to JAK2 Inhibitor Therapy
Shivani Handa, Ganesh Sivakumar, Andrew Srisuwananukorn, et al.
Acta Haematologica
|
June 12, 2025
Ring Chromosomes in Patients with Myeloid Neoplasms are Associated with a Poor Response to Therapy
Daniel I Nathan, Ronald Hoffman, Daiva Ahire, et al.
Clinical Advances in Hematology & Oncology : H&O
|
December 5, 2017
The effect of novel therapies in high-molecular-risk multiple myeloma
Guido Lancman, Douglas Tremblay, Kevin Barley, et al.
Leukemia
|
December 23, 2024
HMGA2 overexpression with specific chromosomal abnormalities predominate in CALR and ASXL1 mutated myelofibrosis
Shivani Handa, Christoph Schaniel, Joseph Tripodi, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
September 15, 2022
Impact of Fluoroquinolone Prophylaxis on Neutropenic Fever, Infections, and Antimicrobial Resistance in Newly Diagnosed AML Patients
Jessica Caro, Rafael Madero-Marroquin, Nicole Zubizarreta, et al.
Leukemia & Lymphoma
|
November 13, 2019
Risk factors for infections and secondary malignancies in patients with a myeloproliferative neoplasm treated with ruxolitinib: a dual-center, propensity score-matched analysis
Douglas Tremblay, Amber King, Lihua Li, et al.
Scientific Reports
|
November 14, 2019
Metabolic Effects of JAK1/2 Inhibition in Patients with Myeloproliferative Neoplasms
Manali Sapre, Douglas Tremblay, Eric Wilck, et al.
Page
of 11